Victory Capital Management Inc Adial Pharmaceuticals, Inc. Transaction History

Victory Capital Management Inc

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2020 Aug 07, 2020	SELL	$29.25 - $50.75 $44,957 - $78,002	-1,537 Closed	0 $0
Q1 2020 May 04, 2020	SELL	$26.25 - $61.75 $918 - $2,161	-35 Reduced 2.23%	1,537 $2,000
Q4 2019 Feb 04, 2020	BUY	$34.5 - $66.0 $3,519 - $6,732	102 Added 6.94%	1,572 $3,000
Q3 2019 Nov 12, 2019	BUY	$36.0 - $42.0 $52,920 - $61,740	1,470 New	1,470 $2,000

5.5K

Ticker ADIL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 26,854,000
Market Cap $26M
Description
Adial Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development of therapeutics for the treatment or prevention of addiction and related disorders. Its lead product is AD04, a selective serotonin-3 antagonist, which is in Phase III clinical trial for the treatment of alcohol use disorder. The company also focu...

Get notified when there are updates to the investment portfolio of Victory Capital Management Inc, based on Form 13F filings with the SEC.

Stay updated on Victory Capital Management Inc with notifications on news.